The Effects of an LED Face Mask & Neck and Chest Mask On Skin Health

NCT07025837 | Completed Results

• 1 other identifier: 20679
• Study Type: interventional
• Target: 38
• Locations: 1 country
• Sites: 1

Brief Summary

This 12-week single-group virtual study evaluates the effects of the iRESTORE Illumina LED Face Mask and Neck \& Chest Mask on skin health in adult females. Participants will use the devices daily for 10 minutes and complete scheduled surveys and photographs to assess improvements in skin appearance via both dermatologist assessment and participant perception.

Conditions

Skin Aging; Sun Damaged Skin

Keywords

Skin Health; Neck and Chest Mask

Outcome Measures

Primary Outcomes (5)

• Percentage of Participants Reported as Having an Improvement in Overall Skin Health as Evaluated by Dermatologist Grading

  Participants will submit photos, which are reviewed by dermatologists using a standardized grading system to evaluate visible changes in overall skin health.

  Baseline, Week 12

• Percentage of Participants Reported as Having an Improvement in Fine Lines and Wrinkles as Evaluated by Dermatologist Grading

  Participants will submit photos, which are reviewed by dermatologists using a standardized grading system to evaluate visible changes in fine lines and wrinkles.

  Baseline, Week 12

• Percentage of Participants Reported as Having an Improvement in Skin Pigmentation as Evaluated by Dermatologist Grading

  Participants will submit photos, which are reviewed by dermatologists using a standardized grading system to evaluate visible changes in skin pigmentation.

  Baseline, Week 12

• Percentage of Participants Reported as Having an Improvement in Skin Redness as Evaluated by Dermatologist Grading

  Participants will submit photos, which are reviewed by dermatologists using a standardized grading system to evaluate visible changes in skin redness.

  Baseline, Week 12.

• Percentage of Participants Reported as Having an Improvement in Signs of Aging as Evaluated by Dermatologist Grading.

  Participants will submit photos, which are reviewed by dermatologists using a standardized grading system to evaluate visible changes in signs of aging.

  Baseline, Week 12

Secondary Outcomes (18)

• Self-Reported Improvement in Overall Skin Hydration

  Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12

• Self-Reported Improvement in Skin Plumpness

  Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12

• Self-Reported Improvement in Skin Tone

  Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12

• Self-Reported Improvement in Skin Texture

  Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12

• Self-Reported Improvement in Facial Skin Glow

  Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12

Study Arms (1)

iRESTORE Illumina LED Device Group

EXPERIMENTAL

All participants will use the iRESTORE LED Face Mask and Neck \& Chest Mask daily for 10 minutes each night. For the face mask, Mode 1 will be used.

Device: iRESTORE Illumina LED Face Mask and Neck & Chest Mask

Interventions

iRESTORE Illumina LED Face Mask and Neck & Chest Mask DEVICE

A pair of light-emitting diode (LED) therapy devices designed for at-home use. The facial and neck/chest masks deliver low-level red light therapy through embedded LEDs to improve visible signs of skin aging.

iRESTORE Illumina LED Device Group

Eligibility Criteria

• Age: 25 Years - 55 Years
• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• Female
• Aged 25-55 years.
• Willing to follow the study protocols.
• Self-reported issues with at least two of the following: Fine lines, Wrinkles, Hyperpigmentation, Dark spots, Reduced elasticity
• Self-report concerns with at least one of the following: Crepey skin on the neck and chest, Sun damage on neck and chest
• Willing to avoid introducing any new products, prescription medications, or supplements that target skin health during the study period.
• If taking oral supplements or herbal remedies targeted at skin health and appearance, have been consistently taking these for at least 3 months prior to starting the study.
• Is willing to maintain the routine of any oral supplements or herbal remedies targeted at skin health and appearance for the duration of the study.
• Has been using the same skincare routine for at least one month prior to the study start date.
• Willing to maintain the same skincare routine and products throughout the study.
• Willing to avoid direct sun exposure during the study duration
• Willing to wear sunscreen if have to be in the sun

You may not qualify if:

• Anyone who is extremely satisfied with their skin.
• Anyone who has any chronic health conditions such as oncological (cancer) or psychiatric disorders.
• Anyone who is planning to undergo facial treatments during the study period, including botox, dermal filler, chemical peels, etc. or has experienced any of these treatments in the last 3 months.
• Anyone diagnosed with a skin condition affecting the face and/or neck who has had an active flare-up or breakout within the last year. This includes but is not limited to acne, eczema, psoriasis, rosacea, seborrheic dermatitis, vitiligo, urticaria (hives), warts, atopic dermatitis, melasma, and contact dermatitis.
• Currently using any prescription medications that may affect the skin condition including but not limited to the following:
• Corticosteroids like prednisone, methylprednisolone
• Antipsychotics like olanzapine (Zyprexa), risperidone (Risperdal), quetiapine (Seroquel)
• SSRIs and SNRIs like fluoxetine (Prozac), sertraline (Zoloft), venlafaxine (Effexor)
• Anticonvulsants like phenytoin (Dilantin), lamotrigine (Lamictal), and carbamazepine (Tegretol)
• Antihypertensives like lisinopril (Zestril), amlodipine (Norvasc), and propranolol (Inderal)
• Antithyroid medications like Tapazole (methimazole), Propyl-Thyracil (propylthiouracil)
• Anyone with a history of skin cancer or precancerous skin lesions on the face.
• Anyone who has any known serious allergic reactions that require the use of an Epi-Pen.
• Anyone who has any known allergies to ingredients commonly found in skincare products.
• Anyone who is pregnant, breastfeeding, or trying to conceive

Sponsors & Collaborators

• Freedom Laser, Inc.: lead
• Citruslabs: collaborator

Study Sites (1)

Citruslabs

Las Vegas, Nevada, 89118, United States

Location

Results Point of Contact

• Title: Patrick Renner
• Organization: Citruslabs

hello@citruslabs.com

4242450285

Publication Agreements

• PI is Sponsor Employee: No
• Restrictive Agreement: No

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 10, 2025
• First Posted: June 18, 2025
• Study Start: October 14, 2024
• Primary Completion: February 5, 2025
• Study Completion: February 5, 2025
• Last Updated: October 14, 2025
• Results First Posted: October 14, 2025

Record last verified: 2025-09

Locations

US (1)